Pages

▼

Wednesday 28 August 2013

Forthcoming attractions in Luxembourg

Not everything in the Grand Duchy is so quite and sedate:
have you tried the Luxembourg Grand Prix ...?
The Curia diary for the coming term has now published the first couple of weeks of impending cases before the Court of Justice of the European Union.  The SPC Blog has been tipped off by one of his anonymous but greatly respected regulars (thanks!) that, if anyone were thinking of taking a holiday in Luxembourg next month, he could do no better than to arrange to be there on Thursday 12 September, in time to enjoy the following fare:

Thursday 12/09/2013
09:30		Hearing
C-443/12
Approximation of laws
Actavis Group and Actavis
Court of Justice - Third Chamber
EN




Thursday 12/09/2013
09:30		Hearing
C-484/12
Approximation of laws
Georgetown University
Court of Justice - Third Chamber
NL
Thursday 12/09/2013
09:30		Hearing
C-493/12
Approximation of laws
Eli Lilly and Company
Court of Justice - Third Chamber
EN
If any SPC Blog devotees happen to be there and feel tempted to let us have a report on how these hearings go, we'd be thrilled to share it with our readers.
at

4 comments:

  1. Anonymous11 September 2013 at 18:18

    Good luck tomorrow guys - the whole pharma IP world is holding its breath as to what the CJEU is going to come up with this time....

    ReplyDelete
  2. Anonymous27 September 2013 at 06:51

    Judge rapporteur Toader mentionned the remarks of Mr J Arnold in another case about the Commission's failure to revize the regulation. She asked why no substantial amendment has been proposed in the frame of 2009 legislative procedure, given the numerous problems that d occurend in the implementation. Agent of the Commission said 2009 was a fast-track procedure without discussion on the substance of the 1992 regulation, but revision has been added on the political Agenda in February 2013 to do it...But when?

    ReplyDelete
  3. Anonymous11 October 2013 at 15:21

    It is all very well saying that the Regulation needs rewriting, but can you imagine the uproar and lobbying that would go on between the generics and innovative industries? I get the impression that these parties would rather slug it out under the current (unclear, and therefore fact-driven) regime than reopen Pandora's Box and risk losing what they have already acheived.

    ReplyDelete
  4. Anonymous26 October 2013 at 12:37

    Thursday 14/11/2013
    09:30 Opinion
    New Great Courtroom C-484/12
    Approximation of lawsGeorgetown University
    Court of Justice - Third Chamber NL New Great Courtroom

    ReplyDelete